Logo image of BOLNV.PA

Bollore SE (BOLNV.PA) Stock Fundamental Analysis

EPA:BOLNV - Euronext Paris - Matif - FR001400XP40 - Common Stock - Currency: EUR

5.247  -0.85 (-13.98%)

Fundamental Rating

4

BOLNV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 47 industry peers in the Entertainment industry. BOLNV has only an average score on both its financial health and profitability. BOLNV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BOLNV had positive earnings in the past year.
BOLNV had a positive operating cash flow in the past year.
Each year in the past 5 years BOLNV has been profitable.
In the past 5 years BOLNV always reported a positive cash flow from operatings.
BOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFBOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

The Return On Assets of BOLNV (6.15%) is better than 76.60% of its industry peers.
With a decent Return On Equity value of 14.99%, BOLNV is doing good in the industry, outperforming 68.09% of the companies in the same industry.
BOLNV's Return On Invested Capital of 0.75% is in line compared to the rest of the industry. BOLNV outperforms 46.81% of its industry peers.
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROIC 0.75%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
BOLNV.PA Yearly ROA, ROE, ROICBOLNV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With an excellent Profit Margin value of 21.69%, BOLNV belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
BOLNV's Profit Margin has improved in the last couple of years.
BOLNV has a Operating Margin (2.75%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 32.15%, BOLNV is doing worse than 72.34% of the companies in the same industry.
In the last couple of years the Gross Margin of BOLNV has declined.
Industry RankSector Rank
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
BOLNV.PA Yearly Profit, Operating, Gross MarginsBOLNV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOLNV is destroying value.
The number of shares outstanding for BOLNV remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BOLNV has less shares outstanding
BOLNV has a better debt/assets ratio than last year.
BOLNV.PA Yearly Shares OutstandingBOLNV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BOLNV.PA Yearly Total Debt VS Total AssetsBOLNV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that BOLNV is in the distress zone and has some risk of bankruptcy.
BOLNV has a Altman-Z score of 1.01. This is comparable to the rest of the industry: BOLNV outperforms 48.94% of its industry peers.
The Debt to FCF ratio of BOLNV is 5.74, which is a neutral value as it means it would take BOLNV, 5.74 years of fcf income to pay off all of its debts.
BOLNV has a Debt to FCF ratio (5.74) which is in line with its industry peers.
A Debt/Equity ratio of 0.13 indicates that BOLNV is not too dependend on debt financing.
The Debt to Equity ratio of BOLNV (0.13) is better than 72.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Altman-Z 1.01
ROIC/WACC0.13
WACC5.85%
BOLNV.PA Yearly LT Debt VS Equity VS FCFBOLNV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.18 indicates that BOLNV should not have too much problems paying its short term obligations.
BOLNV has a better Current ratio (1.18) than 70.21% of its industry peers.
A Quick Ratio of 1.08 indicates that BOLNV should not have too much problems paying its short term obligations.
BOLNV has a Quick ratio of 1.08. This is in the better half of the industry: BOLNV outperforms 65.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.08
BOLNV.PA Yearly Current Assets VS Current LiabilitesBOLNV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2

3. Growth

3.1 Past

BOLNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 700.00%, which is quite impressive.
The Earnings Per Share has been growing by 51.57% on average over the past years. This is a very strong growth
The Revenue has decreased by -1.39% in the past year.
BOLNV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -33.92% yearly.
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -4.24% on average over the next years.
BOLNV is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -46.45% yearly.
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BOLNV.PA Yearly Revenue VS EstimatesBOLNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BOLNV.PA Yearly EPS VS EstimatesBOLNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.20, the valuation of BOLNV can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of BOLNV indicates a rather cheap valuation: BOLNV is cheaper than 93.62% of the companies listed in the same industry.
BOLNV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
BOLNV is valuated quite expensively with a Price/Forward Earnings ratio of 57.72.
BOLNV's Price/Forward Earnings is on the same level as the industry average.
BOLNV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.39.
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
BOLNV.PA Price Earnings VS Forward Price EarningsBOLNV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOLNV indicates a somewhat cheap valuation: BOLNV is cheaper than 61.70% of the companies listed in the same industry.
74.47% of the companies in the same industry are more expensive than BOLNV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.1
EV/EBITDA 8.16
BOLNV.PA Per share dataBOLNV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

BOLNV's earnings are expected to decrease with -4.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.21%
EPS Next 3Y-4.24%

4

5. Dividend

5.1 Amount

BOLNV has a Yearly Dividend Yield of 1.47%.
Compared to an average industry Dividend Yield of 1.83, BOLNV pays a better dividend. On top of this BOLNV pays more dividend than 85.11% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.39, BOLNV is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

The dividend of BOLNV has a limited annual growth rate of 3.53%.
Dividend Growth(5Y)3.53%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

7.97% of the earnings are spent on dividend by BOLNV. This is a low number and sustainable payout ratio.
DP7.97%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
BOLNV.PA Yearly Income VS Free CF VS DividendBOLNV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BOLNV.PA Dividend Payout.BOLNV.PA Dividend Payout, showing the Payout Ratio.BOLNV.PA Dividend Payout.PayoutRetained Earnings

Bollore SE

EPA:BOLNV (5/30/2025, 7:00:00 PM)

5.247

-0.85 (-13.98%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-17 2025-03-17/amc
Earnings (Next)07-28 2025-07-28
Inst Owners12.16%
Inst Owner ChangeN/A
Ins Owners5.79%
Ins Owner ChangeN/A
Market Cap14.74B
Analysts77.5
Price Target5.88 (12.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.06
Dividend Growth(5Y)3.53%
DP7.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.59%
PT rev (3m)-11.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.3%
EPS NY rev (3m)-41.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85.67%
Revenue NY rev (3m)-85.67%
Valuation
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
P/S 0.82
P/FCF 13.1
P/OCF 8.85
P/B 0.56
P/tB 1.9
EV/EBITDA 8.16
EPS(TTM)0.64
EY12.2%
EPS(NY)0.09
Fwd EY1.73%
FCF(TTM)0.4
FCFY7.63%
OCF(TTM)0.59
OCFY11.29%
SpS6.42
BVpS9.3
TBVpS2.76
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROCE 1.01%
ROIC 0.75%
ROICexc 0.88%
ROICexgc 1.59%
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
FCFM 6.24%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Debt/EBITDA 2.18
Cap/Depr 48.98%
Cap/Sales 2.99%
Interest Coverage 6.55
Cash Conversion 104.18%
Profit Quality 28.75%
Current Ratio 1.18
Quick Ratio 1.08
Altman-Z 1.01
F-Score7
WACC5.85%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.01%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A
EBIT growth 1Y17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-81.29%
EBIT Next 3Y-32.79%
EBIT Next 5YN/A
FCF growth 1Y70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.28%
OCF growth 3Y-52.89%
OCF growth 5Y-40.98%